Search Results 661-670 of 1113 for decrease conditional cipher

1. Adjunctive Ganaxolone (GNX) Treatment In Children And Adults With Tuberous Sclerosis Complex (TSC)-related Epilepsy (TrustTSC) - Mayo Clinic

   By condition, treatment or drug name. Search tips ... Generalized motor seizures including tonic-clonic, bilateral tonic, bilateral clonic, or atonic/drop ...

2. Publications - Emily R. Levy, M.D. - Mayo Clinic

   BNT162b2 mRNA Vaccination Against Coronavirus Disease 2019 is Associated With a Decreased Likelihood of Multisystem Inflammatory Syndrome in Children Aged 5-18 ...

3. Investigate the Mechanisms, Predictors, and Prevention of Persistent Post-Traumatic Headache - Mayo Clinic

   By condition, treatment or drug name. Search tips ... History or evidence of any unstable or clinically significant medical condition ... Factors that reduce MR ...

4. Dose Response Study of GSK2330672 for the Treatment of Pruritus in Patients With Primary Biliary Cholangitis - Mayo Clinic

   By condition, treatment or drug name. Search tips ... decreased after institution of ursodeoxycholic ... Any current medical condition (e.g. ...

5. Utility And Effectiveness Of Polygenic Risk Scoring (PRS) For Coronary Artery Disease (CAD) - Mayo Clinic

   By condition, treatment or drug name. Search tips. Utility And Effectiveness ... Currently treated with lipid lowering therapy, including statins ...

6. A Study Of ABBV-383 With Relapsed Refractory Waldenström Macroglobulinemia - Mayo Clinic

   By condition, treatment or drug name. Search tips. A Study Of ABBV-383 With ... lower AND with stable prostate specific antigen levels off treatment; d ...

7. Dose-Escalation Study Of Cevostamab (BFCR4350A) In Participants With Relapsed Or Refractory Multiple Myeloma (R/R MM) - Mayo Clinic

   By condition, treatment or drug name. Search tips. Dose-Escalation Study Of ... Any medical condition or abnormality in clinical laboratory tests that ...

8. Study Of Encorafenib + Cetuximab Plus Or Minus Binimetinib Vs. Irinotecan/Cetuximab Or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With A Safety Lead-in Of Encorafenib + Binimetinib + Cetuximab In Patients With BRAF V600E-mutant Metastatic Colorectal Cancer - Mayo Clinic

   By condition, treatment or drug name. Search tips ... decreased intestinal absorption). Concurrent or ... Other severe, acute or chronic medical or psychiatric ...

9. Publications - Pablo Moreno Franco, M.D. - Mayo Clinic

   Search for a disease or condition . Type 3 or ... decrease the Impella device failure rate: Impact of practice change on patient outcome. ... Hospital-Acquired ...

10. Mayo Clinic Q&A podcast: Men's health - Treating erectile dysfunction

    Since erectile dysfunction also can be a sign of an underlying health condition ... reduce risk of cognitive decline, Alzheimer's. Neurosciences. Brain-body ...